COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE

被引：0
|
作者：
Guzauskas, Gregory [1 ]
Wang, Bruce C. M. [2 ]
Pollom, Erqi [3 ]
Stieber, Volker W. [4 ]
Garrison, Lou [1 ]
机构：
[1] Univ Washington, Dept Pharm, Seattle, WA 98195 USA
[2] Elysia Grp, New York, NY USA
[3] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA
[4] Novant Hlth Forsyth Med Ctr, Dept Radiat Oncol, Winston Salem, NC USA
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
HOUT-18
引用
收藏
页码：116 / 117
页数：2
相关论文
共 50 条
  • [31] Effect of Tumor-Treating Fields plus short-course radiation with or without Temozolomide in elderly patients with Glioblastoma (GERAS Trial)
    Hoene, S. J.
    Krisam, J.
    Jaekel, C.
    Schmitt, D.
    Lang, K.
    El Shafie, R. A.
    Adeberg, S.
    Koenig, L.
    Zimmermann, A. -L
    Hoerner-Rieber, J.
    Rieken, S.
    Kieser, M.
    Debus, J.
    Bernhardt, D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S119 - S120
  • [32] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
    Lazaros Lazaridis
    Niklas Schäfer
    Sarah Teuber-Hanselmann
    Tobias Blau
    Teresa Schmidt
    Christoph Oster
    Johannes Weller
    Theophilos Tzaridis
    Daniela Pierscianek
    Kathy Keyvani
    Christoph Kleinschnitz
    Martin Stuschke
    Björn Scheffler
    Cornelius Deuschl
    Ulrich Sure
    Ulrich Herrlinger
    Sied Kebir
    Martin Glas
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 787 - 792
  • [33] Phase 1 study of concomitant tumor treating fields and temozolomide chemoradiation for newly diagnosed glioblastoma
    Goldlust, Samuel A.
    Singer, Samuel
    Cappello, Lori A.
    AlMekkawi, Ahmad K.
    Lee, Kangmin D.
    Ingenito, Anthony C.
    Lewis, Brett E.
    Nyirenda, Themba
    Azmi, Hooman
    Kaptain, George J.
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [34] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
    Lazaridis, Lazaros
    Schaefer, Niklas
    Teuber-Hanselmann, Sarah
    Blau, Tobias
    Schmidt, Teresa
    Oster, Christoph
    Weller, Johannes
    Tzaridis, Theophilos
    Pierscianek, Daniela
    Keyvani, Kathy
    Kleinschnitz, Christoph
    Stuschke, Martin
    Scheffler, Bjoern
    Deuschl, Cornelius
    Sure, Ulrich
    Herrlinger, Ulrich
    Kebir, Sied
    Glas, Martin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) : 787 - 792
  • [35] RETROSPECTIVE ANALYSIS OF USING RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE AND TUMOR TREATING FIELDS FOR CHINESE PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Wang, Yang
    Wu, Jingsong
    Qin, Zhiyong
    Wang, Enmin
    Yao, Yu
    Zhuang, Dongxiao
    Liang, Lipin
    Ni, Chunxia
    Lu, Peijiang
    Chen, Shu
    Li, Chao
    NEURO-ONCOLOGY, 2021, 23 : 72 - 72
  • [36] Tumor Treating Fields Suppression of Ciliogenesis Enhances Temozolomide Toxicity
    Shi, Ping
    Tian, Jia
    Ulm, Brittany S.
    Mallinger, Julianne C.
    Khoshbouei, Habibeh
    Deleyrolle, Loic P.
    Sarkisian, Matthew R.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Lazaridis, Lazaros
    Schaefer, Niklas
    Kebir, Sied
    Weller, Johannes
    Tzaridis, Theophilos-Dimitrios
    Scheffler, Bjoern
    Pierscianek, Daniela
    Kleinschnitz, Christoph
    Stuschke, Martin
    Sure, Ulrich
    Herrlinger, Ulrich
    Glas, Martin
    NEURO-ONCOLOGY, 2018, 20 : 119 - 120
  • [38] Tumor Treating Fields Combine with Temozolomide for Newly Diagnosed Glioblastoma: A Retrospective Analysis of Chinese Patients in a Single Center
    Chen, Chunjui
    Xu, Hao
    Song, Kun
    Zhang, Yi
    Zhang, Junyan
    Wang, Yang
    Sheng, Xiaofang
    Chen, Lingchao
    Qin, Zhiyong
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [39] Combination of Tumor Treating Fields (TTFields) with lomustine (CCNU) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)
    Lazaridis, L.
    Kebir, S.
    Weller, J.
    Tzaridis, T. -D
    Scheffler, B.
    Pierscianek, D.
    Kleinschnitz, C.
    Stuschke, M.
    Sure, U.
    Herrlinger, U.
    Schaefer, N.
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S109 - S109
  • [40] Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma
    Miller, Ryan
    Song, Andrew
    Ali, Ayesha
    Niazi, Muneeb
    Bar-Ad, Voichita
    Martinez, Nina
    Glass, Jon
    Alnahhas, Iyad
    Andrews, David
    Judy, Kevin
    Evans, James
    Farrell, Christopher
    Werner-Wasik, Maria
    Chervoneva, Inna
    Ly, Michele
    Palmer, Joshua
    Liu, Haisong
    Shi, Wenyin
    FRONTIERS IN ONCOLOGY, 2022, 12
12345